These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 9404444)
1. Anti-GAD65 autoantibody in Taiwanese patients with insulin-dependent diabetes mellitus: effect of HLA on anti-GAD65 positivity and clinical characteristics. Chuang LM; Lin CY; Wu HP; Tsai WY; Tai TY; Lin BJ Clin Endocrinol (Oxf); 1997 Oct; 47(4):455-61. PubMed ID: 9404444 [TBL] [Abstract][Full Text] [Related]
2. Relationships among 64k autoantibodies, pancreatic beta-cell function, HLA-DR antigens and HLA-DQ genes in patients with insulin-dependent diabetes mellitus in Korea. Lee HC; Cha BS; Nam MS; Song YD; Lim SK; Kim DH; Huh KB; Koh Y Korean J Intern Med; 1995 Jan; 10(1):1-9. PubMed ID: 7626550 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I. Tuomi T; Björses P; Falorni A; Partanen J; Perheentupa J; Lernmark A; Miettinen A J Clin Endocrinol Metab; 1996 Apr; 81(4):1488-94. PubMed ID: 8636356 [TBL] [Abstract][Full Text] [Related]
4. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Worsaae A; Hejnaes K; Moody A; Ludvigsson J; Pociot F; Lorenzen T; Dyrberg T Autoimmunity; 1995; 22(3):183-9. PubMed ID: 8734572 [TBL] [Abstract][Full Text] [Related]
5. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus. Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242 [TBL] [Abstract][Full Text] [Related]
6. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status. Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979 [TBL] [Abstract][Full Text] [Related]
7. Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Sugihara S; Sakamaki T; Konda S; Murata A; Wataki K; Kobayashi Y; Minamitani K; Miyamoto S; Sasaki N; Niimi H Diabetes; 1997 Nov; 46(11):1893-7. PubMed ID: 9356042 [TBL] [Abstract][Full Text] [Related]
8. GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus. Chen BH; Chung SB; Chiang W; Chao MC Diabetes Res Clin Pract; 2001 Oct; 54(1):27-32. PubMed ID: 11532327 [TBL] [Abstract][Full Text] [Related]
9. ICA12 autoantibodies are associated with non-DR3/non-DR4 in patients with latent autoimmune diabetes in adults from northern India. Gupta M; Tandon N; Shtauvere-Brameus A; Sanjeevi CB Ann N Y Acad Sci; 2002 Apr; 958():329-32. PubMed ID: 12021135 [TBL] [Abstract][Full Text] [Related]
10. Activation of CD8+ T lymphocytes in insulin-dependent diabetes mellitus. Togun RA; Resetkova E; Kawai K; Enomoto T; Volpé R Clin Immunol Immunopathol; 1997 Mar; 82(3):243-9. PubMed ID: 9073547 [TBL] [Abstract][Full Text] [Related]
11. Association of IA-2 autoantibodies with HLA DR4 phenotypes in IDDM. Genovese S; Bonfanti R; Bazzigaluppi E; Lampasona V; Benazzi E; Bosi E; Chiumello G; Bonifacio E Diabetologia; 1996 Oct; 39(10):1223-6. PubMed ID: 8897011 [TBL] [Abstract][Full Text] [Related]
12. T-cell reactivity to GAD65 peptide sequences shared with coxsackie virus protein in recent-onset IDDM, post-onset IDDM patients and control subjects. Schloot NC; Roep BO; Wegmann DR; Yu L; Wang TB; Eisenbarth GS Diabetologia; 1997 Mar; 40(3):332-8. PubMed ID: 9084973 [TBL] [Abstract][Full Text] [Related]
13. IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry. Gorus FK; Goubert P; Semakula C; Vandewalle CL; De Schepper J; Scheen A; Christie MR; Pipeleers DG Diabetologia; 1997 Jan; 40(1):95-9. PubMed ID: 9028724 [TBL] [Abstract][Full Text] [Related]
14. HLA-DR binding analysis of peptides from islet antigens in IDDM. Geluk A; van Meijgaarden KE; Schloot NC; Drijfhout JW; Ottenhoff TH; Roep BO Diabetes; 1998 Oct; 47(10):1594-601. PubMed ID: 9753297 [TBL] [Abstract][Full Text] [Related]
15. Transcomplementation of HLA DQA1-DQB1 in DR3/DR4 and DR3/DR9 heterozygotes and IDDM in Taiwanese families. Chuang LM; Wu HP; Tsai WY; Lin BJ; Tai TY Diabetes Care; 1995 Nov; 18(11):1483-6. PubMed ID: 8722074 [TBL] [Abstract][Full Text] [Related]
16. Autoantibody negative new onset type 1 diabetic patients lacking high risk HLA alleles in a caucasian population: are these type 1b diabetes cases? Tiberti C; Buzzetti R; Anastasi E; Dotta F; Vasta M; Petrone A; Cervoni M; Torresi P; Vecci E; Multari G; Di Mario U Diabetes Metab Res Rev; 2000; 16(1):8-14. PubMed ID: 10707033 [TBL] [Abstract][Full Text] [Related]
17. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Petersen JS; Hejnaes KR; Moody A; Karlsen AE; Marshall MO; Høier-Madsen M; Boel E; Michelsen BK; Dyrberg T Diabetes; 1994 Mar; 43(3):459-67. PubMed ID: 8314020 [TBL] [Abstract][Full Text] [Related]
18. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. Seissler J; Amann J; Mauch L; Haubruck H; Wolfahrt S; Bieg S; Richter W; Holl R; Heinze E; Northemann W J Clin Invest; 1993 Sep; 92(3):1394-9. PubMed ID: 8376591 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes. Ferber KM; Keller E; Albert ED; Ziegler AG J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800 [TBL] [Abstract][Full Text] [Related]
20. High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65. Akamine H; Komiya I; Shimabukuro T; Asawa T; Tanaka H; Yagi N; Taira T; Nagata K; Arakaki K; Wakugami T; Takasu N; Powell MJ; Furmaniak J; Smith BR Diabet Med; 1997 Sep; 14(9):778-84. PubMed ID: 9300229 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]